Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 7 publications
Safety of Enteral Feeding in Patients on High-Flow Nasal Cannula.
Journal: Critical care medicine
Published: February 18, 2026
Preclinical development of a bispecific TNFα/IL-23 neutralising domain antibody as a novel oral treatment for inflammatory bowel disease.
Journal: Scientific reports
Published: May 24, 2021
Ophthalmologic characteristics and outcomes of children with cortical visual impairment and cerebral palsy.
Journal: Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus
Published: January 07, 2021
Oral Anti-Tumour Necrosis Factor Domain Antibody V565 Provides High Intestinal Concentrations, and Reduces Markers of Inflammation in Ulcerative Colitis Patients.
Journal: Scientific reports
Published: March 19, 2019
Oral delivery of the anti-tumor necrosis factor α domain antibody, V565, results in high intestinal and fecal concentrations with minimal systemic exposure in cynomolgus monkeys.
Journal: Drug development and industrial pharmacy
Published: November 06, 2018
Preclinical Development of a Novel, Orally-Administered Anti-Tumour Necrosis Factor Domain Antibody for the Treatment of Inflammatory Bowel Disease.
Journal: Scientific reports
Published: January 06, 2018
The Clostridium difficile spo0A gene is a persistence and transmission factor.
Journal: Infection and immunity
Published: May 23, 2012
Showing 1-7 of 7
Last Updated: 09/26/2026